Dr. Len Friedland, Vice President and Director, Scientific Affairs and Public Health, Vaccines, at GSK discusses how the ordering rate of adult vaccines among healthcare practices has dropped an average of 62 percent since the declaration of COVID-19. He also discusses the findings of a Harris Poll conducted online on behalf of GSK of 3,000 US adults ages 50-79 and 300 US primary care physicians. He is joined by Alice who experienced shingles.
Dr. Len Friedland is Vice President and Director, Scientific Affairs and Public Health, Vaccines, at GSK. He is also a licensed pediatrician in the state of Pennsylvania. Dr. Friedland has held many positions in clinical research and development with GSK since 2003, specializing in infectious disease vaccination. Prior to his work at GSK, Dr. Friedland was Division Chief, Pediatric Emergency Medicine at Temple University School of Medicine. Dr. Friedland studied medicine at Mount Sinai School of Medicine in New York and conducted his residency in pediatrics at the Children’s Hospital of Philadelphia and his fellowship in pediatric emergency medicine at St. Christopher’s Hospital for Children, also in Philadelphia. He is a fellow of the American Academy of Pediatrics, the past Alternate Industry Representative to the FDA Vaccines and Related Biologics Product Advisory Committee, the current Alternate Industry Representative to the FDA Allergenic Products Advisory Committee and the Industry Representative Member on the Department of Health and Human Services National Vaccine Advisory Committee. He has published over 50 peer reviewed articles as well as book chapters on healthcare and vaccination topics during his career.